title: Virological, immunological and histological aspects in adult beta-thalassemic patients with chronic hepatitis C virus infection.
abstract: OBJECTIVE
  Multitransfused adult beta-thalassemic patients constitute a population with high prevalence of hepatitis C virus (HCV) infection, because of transmission of HCV from infected blood donors prior to the introduction of anti-HCV screening. The aim of this study was to compare them with otherwise normal patients with HCV infection.
  
  
  METHODS
  Forty-two adult multitransfused beta-thalassemics and 49 otherwise normal patients of the same age, with chronic HCV infection were studied. Viral parameters, autoimmunity indices and liver histology were evaluated.
  
  
  RESULTS
  Serum HCV RNA levels were found significantly lower in thalassemic (median: 65,150 international units per milliliter (IU/ml); range: 3 059 380 IU/ml) than in non-thalassemic (NT) patients (median: 580,000 IU/ml; range: 10,956,000 IU/ml; P=0.001). The most prevalent genotype in thalassemic group was genotype 4 (32.4%) while in NT group was genotype 3a (59.2%). Cryoglobulins were detected in 8/42 (19%) thalassemic patients and in 12/49 (24.5%) NTs. Thalassemic patients had significantly lower levels of C3 and C4 components of complement and higher incidence of anti-nuclear antibodies than those without thalassemia. In patients with thalassemia a lower grading score was noted in liver biopsy compared with those without thalassemia (4.41+/-1.98 vs 5.38 +/- 2.09, P=0.038). On the contrary, thalassemic patients were found to have a higher staging score (3.08 +/- 1.51 vs 2.33 +/- 1.34, P=0.024).
  
  
  CONCLUSIONS
  Adult beta-thalassemic patients, compared with other patients with HCV infection, present lower necroinflammatory activity and lower viral load but higher staging score. Autoimmune features are marginally different. Age of acquiring the infection, iron overload and modulation of immune system by transfusions are the proposed causes of these differences.
authors.affiliation: Department of Internal Medicine, Patras University Hospital, Greece.
authors.forename: D
authors.initials: D
authors.lastname: Siagris
authors.forename: N
authors.initials: N
authors.lastname: Giannakoulas
authors.forename: M
authors.initials: M
authors.lastname: Christofidou
authors.forename: A
authors.initials: A
authors.lastname: Tsamandas
authors.forename: A
authors.initials: A
authors.lastname: Lekkou
authors.forename: K
authors.initials: K
authors.lastname: Thomopoulos
authors.forename: N
authors.initials: N
authors.lastname: Zoumbos
authors.forename: Ch
authors.initials: Ch
authors.lastname: Labropoulou-Karatza
mesh_terms: D000328:Adult; D001323:Autoantibodies / Q000032:analysis*; D003165:Complement System Proteins / Q000032:analysis*; D003449:Cryoglobulinemia / Q000453:epidemiology / Q000209:etiology*; D005260:Female; D016174:Hepacivirus / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000821:virology; D006801:Humans; D008099:Liver / Q000473:pathology; D008297:Male; D015995:Prevalence; D012367:RNA, Viral / Q000032:analysis*; D017086:beta-Thalassemia / Q000150:complications* / Q000276:immunology / Q000473:pathology*
chemical_list: D001323:Autoantibodies; D012367:RNA, Viral; D003165:Complement System Proteins